VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
The company has introduced an innovative Dual Release Proton Pump Inhibitor (PPI) tablet, a next-generation therapy for patients suffering from moderate to severe or treatment resistant gastroesophageal reflux disease
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
AI-powered cardiometabolic wellness platform for India’s workforce
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
The event will be attended by 35,000+ industry professionals
The company’s “greener” initiatives emphasize eco-friendly excipients and energy-efficient manufacturing processes that reduce environmental impact without compromising product quality
Based on these promising results, Johnson & Johnson plans to move the program into a Phase 3 trial to further investigate subcutaneous amivantamab
This new facility strengthens Latin America as a collaborative hub
Lutavit A/D3 1000/200 NXT provides a combination of vitamin A and vitamin D3 in one formulation
Subscribe To Our Newsletter & Stay Updated
